Skip to main content
OpenTrials
Completed

NCT Number: NCT04810065

SingStrong: Strong Lungs Through Song - Long COVID-19 Study

Evidence is emerging that many individuals who recover from Covid-19 are experiencing a range of residual problems. These include fatigue, pain, reduced exercise tolerance and breathing issues. This study includes participants who are experiencing problems with their lungs such as breathing difficulties, shortness of breath, and/or reduced exercise tolerance. The intervention is a twice weekly singing and breathing retraining intervention conducted over ten weeks. A range of self-report questionnaire measures will evaluate the efficacy of the intervention in addressing these problems. Focus groups and individual interviews will also be used to gather information on the impact and acceptability of the programme.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Previous clinical diagnosis of Covid-19
  • Ongoing issues with any or all of: Shortness of breath, disordered breathing, reduced exercise tolerance
  • Good written and spoken English language

Exclusion criteria

  • Lack of a confirmed Covid-19 diagnosis
  • Currently undergoing a similar singing or breathing retraining intervention
  • No residual problems from a confirmed case of Covid-19

Treatment and study plan

SingStrong: Strong lungs through Song

Other

Participants who have been clinically diagnosed with Covid-19 and who continue to suffer residual adverse effects on the lung health will be invited to participate in the study.

The intervention will involve biweekly hour-long breathing and singing classes that are designed to correct dis-ordered breathing, and retrain the principal muscles of respiration.

Pre and post evaluation of participant bio-psychosocial health and wellness will be conducted. Triangulation of data using focus groups and individual interviews will be conducted after conclusion of the intervention,

Primary outcomes

  1. Covid-19 Yorkshire Rehab Screen (C19YRS)

    Time frame: 12 weeks

    The C19YRS was developed as a screening tool to monitor long-term symptoms due to Covid-19. The screening tool covers 19 items which combines yes/no answers and an 11 point ordinal scale (0-10) where a higher score denotes increased symptom severity.

Secondary outcomes

  1. DePaul Symptom Questionnaire - Short Form DSQ - SF

    Time frame: 12 weeks

    The DPSQ -SF assesses key symptoms of ME/Chronic Fatigue Syndrome such as fatigue, post-exertional malaise, sleep, pain, neurological/cognitive impairments and autonomic, neuroendocrine and immune symptoms. At each item, participants have to rate the frequency and severity of the symptom on a scale from 0 to 4. A higher score denotes increased symptom severity.

Sponsors and collaborators

Lead sponsor

University of Limerick

Other

Registry information

Official study title

SingStrong: Strong Lungs Through Song

Acronym: ss

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 22, 2021
Registry last updated
Sep 28, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.